News for Shanghai Pharmaceuticals Holding Co., Ltd (2607.HK)

HONG KONG, Feb. 24, 2025 /PRNewswire/ -- The Preparatory Committee and Expert Advisory Committee for the New Medical School set up by Hong Kong Baptist University (HKBU) held a meeting yesterday (23 February), during which progress of the preparation of the University's new medical school proposal was discussed and unanimously supported by all the committee members. With the backing of 2020 Nobel Laureate Sir Michael Houghton and drug development expert Dr Robert J Spiegel, HKBU will establish a translational medical research institute poised to fuel future medical innovation and technology translation.

**media[503662]**

HUTCHMED Announces US$608 million Divestment of Non-Core Joint  Venture

Shanghai Pharmaceuticals Holding Company Limited (601607 SH): Profitable Growth rank of 9 was same compared to the prior period’s 9th rank.

The SERDs market is expected to grow significantly in the coming years. This is due to the increasing cancer diagnosis, high unmet need in ESR1 mutation...

The rising global incidence of breast cancer, driven by lifestyle changes and an aging population, is a key market driver. Technological advancements in...

The dynamics of the cluster headache market are anticipated to change during the forecast period (2023–2032) owing to the rising prevalence of cluster...

DelveInsight analysts project a favorable treatment-resistant hypertension market expansion, primarily driven by a rise in prevalence and the expected...

Several approved therapies such as EYBELIS, Durysta, Alphagan-P, Rhopressa, etc. will drive the current therapeutic landscape of ocular hypertension in the...

The dynamics of the osteosarcoma market are anticipated to change in the coming years owing to the improvement in the diagnosis methodologies, rising...

The emergence of new products in the pipeline will add to the soft tissue sarcoma market growth in the future. In addition, persistently rising cases of...

/PRNewswire/ -- DelveInsight's Hypertension Market Insights report includes a comprehensive understanding of current treatment practices, hypertension emerging...

/PRNewswire/ -- DelveInsight's 'Soft Tissue Sarcoma Pipeline Insight – 2023' report provides comprehensive global coverage of available, marketed, and pipeline...

As per a statement of World Health Organization (WHO), Hypertension is one of the silent killers in 21st century and is one of the biggest global public...